Amid the current market turmoil, this is our regular report on hedge fund and alternative asset managers who are bucking the trend.

Life sciences outperform

DAFNA Capital's flagship DAFNA Life Sciences fund was able to preserve capital throughout the first quarter. The fund has an annualized return of 20.7%. According to a performance upd